Trademark: TERLIVAZ TERLIPRESSIN FOR INJECTION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
TERLIVAZ TERLIPRESSIN FOR INJECTION
Click here to search for trademarks similar to TERLIVAZ TERLIPRESSIN FOR INJECTION
Proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION
We do not have any records of a proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION at this moment.
Click here to add a proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION
Possible trademark infringements of TERLIVAZ TERLIPRESSIN FOR INJECTION
Basic Information about TERLIVAZ TERLIPRESSIN FOR INJECTION
- Serial Number
- 88900093
- Filing Date
- 04 May 2020
- Registration Number
- 7081079
- Registration Date
- 13 Jun 2023
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of TERLIVAZ TERLIPRESSIN FOR INJECTION on the blockchain with WikiTrademarks.io.
- First use of TERLIVAZ TERLIPRESSIN FOR INJECTION anywhere
- TERLIVAZ TERLIPRESSIN FOR INJECTION was first used on 12 Oct 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns TERLIVAZ TERLIPRESSIN FOR INJECTION?
1. MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED DUBLIN 15
2. MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED DUBLIN 15
3. Mallinckrodt Hospital Products IP Limited Dublin 15
4. Mallinckrodt Hospital Products IP Limited Dublin 15
Correspondent
- Carlynn Ferguson
- IPHORGAN LTD.
- 195 NORTH ARLINGTON HEIGHTS ROAD
- SUITE 125
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io